Skip to main content


Page 1 of 35

  1. Bladder cancer stem cells (BCSCs) are considered as the root cause of BC initiation and recurrence, and exosomes derived from BCSCs (CSCs-exo) are the vital tool for establishing a stable tumor microenvironmen...

    Authors: Gaojian Pan, Bo Jiang, Zhongquan Yi, Jiuhu Yin and Yadong Liu
    Citation: BMC Urology 2023 23:155
  2. Patients with benign prostatic hyperplasia (BPH) receive α-blockers as first-line therapy to treat lower urinary tract symptoms; however, some individuals still experience residual storage symptoms. Antimuscar...

    Authors: Yi-Ting Su, Hsiao-Ling Chen, Jeremy Yuen-Chun Teoh, Vinson Wai-Shun Chan, Wen-Jeng Wu and Hsiang-Ying Lee
    Citation: BMC Urology 2023 23:154
  3. Active surveillance has been proposed as a therapeutic option in selected intermediate risk patients with biopsy grade group 2 prostate cancer. However, its oncologic safety in this setting is debated. Therefo...

    Authors: Giorgio Gandaglia, Riccardo Leni, Sophie Plagakis, Armando Stabile, Francesco Montorsi and Alberto Briganti
    Citation: BMC Urology 2023 23:153
  4. Treatment decisions for localized prostate cancer must balance patient preferences, oncologic risk, and preservation of sexual, urinary and bowel function. While Active Surveillance (AS) is the recommended opt...

    Authors: Kelly R. Pekala, Oskar Bergengren, James A. Eastham and Sigrid V. Carlsson
    Citation: BMC Urology 2023 23:152
  5. Finding some convenient and economical indicators to initially screen overweight and obese patients at high risk of kidney stone recurrence can help them prevent stone recurrence with lower medical cost. The p...

    Authors: Kaiguo Xia, Yuexian Xu, Qiao Qi, Jiashan Pan, Rui Yao, Qingfeng Huang and Zongyao Hao
    Citation: BMC Urology 2023 23:151
  6. There is a tendency of prompted global health systems to reduce the length of hospital stay without compromising patient safety or satisfaction. We evaluated the safety and viability of early discharge in pati...

    Authors: Eliney Ferreira Faria, Roberto Dias Machado, Rodrigo José Costa Gualberto, Marina Assunção Valadares Milani, Lucas Tadeu Bidinotto, Marcos Tobias Machado, Ricardo dos Reis and Daniele Natália Pacharone Bertolini Bidinotto
    Citation: BMC Urology 2023 23:149
  7. Metabolism reprogramming is a hallmark that associates tumor growth, metastasis, progressive, and poor prognosis. However, the metabolism-related molecular patterns and mechanism in clear cell renal cell carci...

    Authors: Rongfen Tai, Jinjun Leng, Wei Li, Yuerong Wu and Junfeng Yang
    Citation: BMC Urology 2023 23:147
  8. To evaluate three partial nephrectomies (PN) procedures: open (OPN), standard laparoscopy (LPN), and robot-assisted laparoscopy (RAPN), for the risk of initial complications and rehospitalization for two years...

    Authors: Antoine Bic, Charles Mazeaud, Julia Salleron, Aurélie Bannay, Beverley Balkau, Clément Larose, Jacques Hubert and Pascal Eschwège
    Citation: BMC Urology 2023 23:146
  9. The therapeutic role of extracorporeal shockwave therapy (ESWT) for Peyronie’s disease (PD) has been controversial in a long term. We aimed to further evaluate the therapeutic effect of ESWT for PD on the basi...

    Authors: Xiaofeng Wang, Hongquan Liu, Gonglin Tang, Gang Wu, Yongli Chu, Jitao Wu and Yuanshan Cui
    Citation: BMC Urology 2023 23:145
  10. The application of a second layer between the neourethra and skin was a major contribution, which has improved the outcome of hypospadias repair. Here, we report our experience of revisiting the original Smith...

    Authors: Amr Abdelhamid AbouZeid, Reda Abualyazeed Habak, Mostafa Mahmoud Hamad and Alaa-Eldin Medhat Shahin
    Citation: BMC Urology 2023 23:143
  11. To share our experience using transurethral ultrasound ablation (TULSA) treatment for focal therapy of localized prostate cancer (PCa).

    Authors: Inga Peters, Bennet Hensen, Julian Glandorf, Marcel Gutberlet, Martha Dohna, Steffen Struckmann, Markus Antonius Kuczyk, Frank Wacker and Susanne Hellms
    Citation: BMC Urology 2023 23:142
  12. We aimed to compare the impact of urethral transection after different techniques of bulbar urethroplasty on erectile function outcome.

    Authors: Osama Shalkamy, Mohamed Elsalhy, Saleh Mohammed Alghamdi, Mohammed Beaiti, Ibrahim Abdel-Al, Mahmoud Faisal, Tamer A. Abouelgreed, Yasser Badran, Abdrabu Abdrabu, Mahdi Al-Ayafi, Mohanad Jebril Bosily, Salah E. Shebl, Ibrahim nematallah, Ahmed Shafiea and Adel Elatreisy
    Citation: BMC Urology 2023 23:140
  13. Patients with localized prostate cancer (PC) are faced with a wide spectrum of therapeutic options at initial diagnosis. Following radical prostatectomy (RP), PC patients may experience regret regarding their ...

    Authors: Lukas Lunger, Valentin H. Meissner, Benedikt C. G. Kopp, Andreas Dinkel, Stefan Schiele, Donna P. Ankerst, Jürgen E. Gschwend and Kathleen Herkommer
    Citation: BMC Urology 2023 23:139
  14. Congenital renal anomalies are rare but may be associated with obstruction of the ureteropelvic junction. Given the rarity of simultaneous ureteropelvic junction obstruction [UPJO] and renal anomalies in the a...

    Authors: Sarah Razavi, Joshua Babbin and Douglas Dahl
    Citation: BMC Urology 2023 23:138
  15. Lymph node metastasis is the main determinant of survival in penile cancer patients. Conventionally clinical palpability is used to stratify patients to Inguinal Lymph node dissection (ILND) if clinically node...

    Authors: Vivekanandan Kumar, Prakrit R Kumar, Arne Juette, Davina Pawaroo, Richard Y Ball and Krishna K Sethia
    Citation: BMC Urology 2023 23:137
  16. Bladder cancer (BLCA) is one of the most common malignancies among tumors worldwide. There are no validated biomarkers to facilitate such treatment diagnosis. DNA methylation modification plays important roles...

    Authors: Hongxia Cheng, Yuhua Liu and Gang Chen
    Citation: BMC Urology 2023 23:135
  17. An arteriovenous fistula is an abnormal communication between an artery and a vein. Traumatic penile arteriospongious fistula is a rare complication and has been described as a cause of erectile dysfunction. C...

    Authors: Polona Vihtelič, Simon Hawlina and Peter Popovič
    Citation: BMC Urology 2023 23:134
  18. The use of postoperative prophylactic antibiotics in pediatric upper urinary tract reconstruction remains controversial. In this study, we examined whether low dose antibiotics administered following pediatric...

    Authors: Kunj Sheth, Kathleen Puttmann, Paige Nichols, Jordon C. King, Huirong Zhu, Sheila Ryan, Andrew T. Gabrielson and Ming-Hsien Wang
    Citation: BMC Urology 2023 23:133
  19. Cystinuria and xanthinuria are both rare genetic diseases involving urinary calculi. However, cases combining these two disorders have not yet been reported.

    Authors: Peide Bai, WenZhao Zhang, Longhui Lai, Haichao Huang, Jiaxuan Qin, Bo Duan, Huiqiang Wang, Yuedong Chen, Yuanyuan Jia, Jinchun Xing, Tao Wang and Bin Chen
    Citation: BMC Urology 2023 23:130
  20. Transplant renal artery aneurysm (TRAA) is rare. TRAA that develops post transplantation consists of 0.10% of the vascular complications post renal transplant (Transplant Proc 41:1609-1614, 2009; Indian J Urol...

    Authors: Collin Elijah Rui Hung Ho, Wei Zheng So, Julian Wong and Ho Yee Tiong
    Citation: BMC Urology 2023 23:129
  21. Management of a bladder tumor during pregnancy is an uncommon clinical situation. Leiomyosarcoma of the urinary bladder is a rare histological type of bladder tumor and a rare secondary cancer in survivors of ...

    Authors: Hayato Hoshina, Satoru Taguchi, Hikaru Suyama, Kenjiro Kishitani, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Naoya Akiba, Keiichi Kumasawa, Mayuyo Mori-Uchino, Yutaka Osuga and Haruki Kume
    Citation: BMC Urology 2023 23:125
  22. Radical prostatectomy remains the fundamental treatment for prostate cancer, and improving patients’ compliance with postoperative follow-ups is essential for improving patients’ quality of life. This study in...

    Authors: Jin Ji, Yuchen Yang, Zeyu Chen, Wenhui Zhang, Shaoqin Jiang, Xianqi Shen, Jili Zhang, Lu Lin, Min Qu, Yan Wang and Xu Gao
    Citation: BMC Urology 2023 23:123
  23. Traditional estimates can only provide static predictions of cancer outcomes and cannot assess the evolving effect of race on patient survival. This study aims to reveal the dynamic survival of patients with b...

    Authors: Wei Liu, Jie Xiong, Honghao Wang, Shuo Li, Zhentao Lei, Lili Jiang, Jin Cao, Lin Yang, Hongfeng Guo, Qiang Gao, Shenghan Wang and Bao Zhang
    Citation: BMC Urology 2023 23:122
  24. I kappa B kinase interacting protein, a highly conserved gene, has rarely been reported in cancer. According to previous study, IKBIP has only been shown to promote malignant progression of glioma. In other ma...

    Authors: Huiling Zhang, Rui Tang, Xue Wen, Jingbo Cai, Juan Huang, Li Luo and Zhihui Yang
    Citation: BMC Urology 2023 23:121
  25. This study aimed to explore the value of combined serum lipids with clinical symptoms to diagnose prostate cancer (PCa), and to develop and validate a Nomogram and prediction model to better select patients at...

    Authors: Fu Feng, Yu-Xiang Zhong, Yang Chen, Fu-Xiang Lin, Jian-Hua Huang, Yuan Mai, Peng-Peng Zhao, Wei Wei, Hua-Cai Zhu and Zhan-Ping Xu
    Citation: BMC Urology 2023 23:120
  26. Studies have suggested a positive association between bladder cancer (BC) outcome and comedication use, including nonsteroidal anti-inflammatory drugs (NSAID), metformin, and prednisone use. To validate these ...

    Authors: Michel D. Wissing, Ana O’Flaherty, Alice Dragomir, Simon Tanguay, Wassim Kassouf and Armen G. Aprikian
    Citation: BMC Urology 2023 23:119
  27. Myelolipoma is a benign neoplasm of the adrenal cortex, composed of fat and hematopoietic cells. Although myelolipoma is benign, differentiation from adrenocortical cancer may be difficult. The presence of adr...

    Authors: Hooman Kamran, Abdolreza Haghpanah, Mohammad Hossein Dabbaghmanesh, Lorenzo Defidio, Maryam Bazrafkan, Anahita Dehghani, Mehdi Shirazi, Nima Naderi and Amirreza Dehghanian
    Citation: BMC Urology 2023 23:114
  28. Comparing stone-free rates and associated outcome measures between two surgical modalities of lithotripsy fragmentation and removal or spontaneous passage of dust during retrograde intrarenal surgery (RIRS).

    Authors: Zhi Wen, Li Wang, Yang Liu, Jing Huang, Cai-Xia Chen, Chong-Jian Wang, Lin-Lin Chen and Xue-song Yang
    Citation: BMC Urology 2023 23:113
  29. Nephroureterectomy remains the gold standard treatment for upper tract urothelial carcinoma (UTUC). Considering the high risk of developing renal function impairment after surgery, the rationale for nephron sp...

    Authors: Ahmad Abdelaziz, Mark Sultan, Muhammed A Hammad, Juan Ramon Martinez Jr, Maria Yacoub and Ramy F Youssef
    Citation: BMC Urology 2023 23:111
  30. Traditionally, a pigtail catheter (PCN) is placed for preoperative renal access before performing percutaneous nephrolithotomy (PCNL). However, PCN can hamper the passage of the guidewire to the ureter, due to...

    Authors: Jun-Koo Kang, Sang Hee Lee, Seok-Gi Kim, Ju-Bin Kim, Jeong-Yeon Lee, Seon-Yeon Ha, Chan-Geun Ha, Soon-Ho Hong, Jae-Wook Chung, Yun-Sok Ha, Jun Nyung Lee, So Young Chun and Bum Soo Kim
    Citation: BMC Urology 2023 23:109
  31. Immune checkpoint inhibitors (ICIs) have been approved for the treatment of metastatic renal cell carcinoma (mRCC). However, the response rate is still limited, and it is urgent to pursue novel and concise mar...

    Authors: Soichi Matsumura, Taigo Kato, Yuma Kujime, Hiroaki Kitakaze, Kosuke Nakano, Sachiko Hongo, Iwao Yoshioka, Masayoshi Okumi, Norio Nonomura and Shingo Takada
    Citation: BMC Urology 2023 23:107
  32. As a high-quality TUR-BT is important to ensure adequate treatment for bladder cancer patients, the aim of the current study is to investigate the impact of patient-related, surgical and tumor-specific paramet...

    Authors: Yannic Volz, Rabea Trappmann, Benedikt Ebner, Lennert Eismann, Nikolaos Pyrgidis, Paulo Pfitzinger, Robert Bischoff, Boris Schlenker, Christian Stief and Gerald Bastian Schulz
    Citation: BMC Urology 2023 23:106

Affiliated with

  • BMC Urology works with with Cochrane Urology in providing our authors with expert advice on systematic reviews and meta-analyses

Annual Journal Metrics

  • 2022 Citation Impact
    2.0 - 2-year Impact Factor
    2.2 - 5-year Impact Factor
    1.177 - SNIP (Source Normalized Impact per Paper)
    0.616 - SJR (SCImago Journal Rank)

    2022 Speed
    19 days submission to first editorial decision for all manuscripts (Median)
    145 days submission to accept (Median)

    2022 Usage 
    1,128 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal